X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (3697) 3697
Publication (281) 281
Newsletter (104) 104
Book Review (51) 51
Newspaper Article (24) 24
Magazine Article (22) 22
Book / eBook (4) 4
Book Chapter (2) 2
Government Document (2) 2
Reference (2) 2
Trade Publication Article (2) 2
Data Set (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (3129) 3129
zidovudine (1954) 1954
female (1841) 1841
hiv infections - drug therapy (1702) 1702
male (1648) 1648
adult (1487) 1487
zidovudine - adverse effects (1296) 1296
zidovudine - therapeutic use (1215) 1215
hiv (938) 938
infectious diseases (911) 911
anti-hiv agents - therapeutic use (871) 871
anti-hiv agents - adverse effects (843) 843
aids (758) 758
middle aged (728) 728
index medicus (727) 727
drug therapy, combination (706) 706
pregnancy (673) 673
zidovudine - administration & dosage (609) 609
immunology (594) 594
drug therapy (561) 561
hiv infection (545) 545
human-immunodeficiency-virus (526) 526
antiretroviral therapy (512) 512
acquired immunodeficiency syndrome - drug therapy (506) 506
pharmacology & pharmacy (505) 505
medicine, general & internal (428) 428
cd4 lymphocyte count (419) 419
infant, newborn (417) 417
hiv infections - transmission (413) 413
hiv infections - prevention & control (385) 385
lamivudine (383) 383
anti-hiv agents - administration & dosage (379) 379
risk factors (376) 376
hiv-1 (373) 373
virology (370) 370
therapy (357) 357
viral load (357) 357
infectious disease transmission, vertical - prevention & control (348) 348
treatment outcome (343) 343
reverse transcriptase inhibitors - therapeutic use (339) 339
human immunodeficiency virus--hiv (337) 337
animals (336) 336
health aspects (333) 333
antiviral agents (330) 330
infant (323) 323
reverse transcriptase inhibitors - adverse effects (319) 319
hiv infections - complications (316) 316
lamivudine - therapeutic use (311) 311
highly active antiretroviral therapy (295) 295
hiv infections - virology (283) 283
adolescent (281) 281
antiretroviral drugs (280) 280
pregnancy complications, infectious - drug therapy (280) 280
infection (279) 279
research (270) 270
human immunodeficiency virus (268) 268
hiv infections - immunology (267) 267
prevention (263) 263
lamivudine - adverse effects (252) 252
toxicity (248) 248
hiv-1 - drug effects (245) 245
child (242) 242
protease inhibitors (223) 223
prospective studies (220) 220
nevirapine (219) 219
time factors (216) 216
antiretroviral therapy, highly active - adverse effects (213) 213
acquired immunodeficiency syndrome - complications (205) 205
microbiology (205) 205
pharmacokinetics (204) 204
aged (200) 200
drug administration schedule (200) 200
lamivudine - administration & dosage (200) 200
double-blind (198) 198
antiretroviral therapy, highly active (194) 194
aids-related complex (193) 193
didanosine - therapeutic use (192) 192
zidovudine - pharmacology (190) 190
acquired immune deficiency syndrome--aids (188) 188
antiviral agents - therapeutic use (188) 188
retrospective studies (188) 188
stavudine (188) 188
adverse and side effects (187) 187
follow-up studies (187) 187
double-blind method (186) 186
placebo-controlled trial (182) 182
child, preschool (179) 179
didanosine - adverse effects (175) 175
children (174) 174
antiviral agents - adverse effects (173) 173
didanosine (173) 173
hiv protease inhibitors - therapeutic use (173) 173
infants (171) 171
rna, viral - blood (167) 167
azt (166) 166
drug interactions (165) 165
evaluation (165) 165
cohort studies (164) 164
dosage and administration (164) 164
stavudine - adverse effects (164) 164
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (3646) 3646
French (67) 67
German (54) 54
Spanish (47) 47
Japanese (12) 12
Dutch (8) 8
Italian (7) 7
Danish (5) 5
Chinese (3) 3
Portuguese (2) 2
Serbian (2) 2
Hungarian (1) 1
Polish (1) 1
Russian (1) 1
Swedish (1) 1
Turkish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


CNS Drugs, ISSN 1172-7047, 2/2014, Volume 28, Issue 2, pp. 131 - 145
Antiretroviral drugs are associated with a variety of adverse effects on the central and peripheral nervous systems. The frequency and severity of... 
Pharmacotherapy | Neurology | Neurosciences | Medicine & Public Health | Psychiatry | Psychopharmacology | EFAVIRENZ DOSE REDUCTION | PSYCHIATRY | GUILLAIN-BARRE-SYNDROME | HUMAN-IMMUNODEFICIENCY-VIRUS | CLINICAL NEUROLOGY | HIV-INFECTED PATIENTS | UNINFECTED CHILDREN BORN | REVERSE-TRANSCRIPTASE INHIBITORS | PHARMACOLOGY & PHARMACY | HEREDITARY OPTIC NEUROPATHY | PLACEBO-CONTROLLED TRIAL | PERSISTENT MITOCHONDRIAL DYSFUNCTION | ZIDOVUDINE-INDUCED MYOPATHY | Peripheral Nervous System Diseases - diagnosis | Peripheral Nervous System Diseases - epidemiology | Anti-Retroviral Agents - therapeutic use | Neurotoxicity Syndromes - diagnosis | Peripheral Nervous System Diseases - chemically induced | Mental Disorders - epidemiology | Mental Disorders - chemically induced | Humans | Anti-Retroviral Agents - adverse effects | Anti-Retroviral Agents - pharmacology | Peripheral Nervous System Diseases - enzymology | Treatment Outcome | Clinical Trials as Topic | Mental Disorders - psychology | Neurotoxicity Syndromes - etiology | Neurotoxicity Syndromes - enzymology | Mental Disorders - enzymology | Anti-Retroviral Agents - administration & dosage | DNA-Directed DNA Polymerase - metabolism | Neurotoxicity Syndromes - epidemiology | Stroke (Disease) | Antiviral agents | Complications and side effects | Insomnia | Analysis | Cytochrome P-450 | Risk factors | Antiretroviral drugs | Neurotoxicity | Pathogenesis | Toxicity | Medical treatment | Older people | Mortality | Suicides & suicide attempts | Clinical trials | Mitochondrial DNA | Drug dosages | Index Medicus
Journal Article
Lancet, The, ISSN 0140-6736, 2007, Volume 370, Issue 9581, pp. 12 - 14
Journal Article
AIDS (London, England), ISSN 0269-9370, 2012, Volume 26, Issue 5, pp. 567 - 575
Journal Article
Toxicology in Vitro, ISSN 0887-2333, 03/2011, Volume 25, Issue 2, pp. 485 - 491
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 01/2006, Volume 354, Issue 3, pp. 251 - 260
Journal Article
The Journal of Infectious Diseases, ISSN 0022-1899, 4/2013, Volume 207, Issue 7, pp. 1157 - 1165
Background. Human immunodeficiency virus (HIV)-infected patients on combination active antiretroviral therapy (cART) are at increased risk of age-related... 
T lymphocytes | HIV/AIDS | Telomeres | Antiretrovirals | HIV | Final causes | Cell lines | Nucleosides | Reverse transcriptase inhibitors | Carts | Disease risks | telomerase | aging | HIV infection | antiretroviral therapy | telomere | INFECTIOUS DISEASES | HUMAN HL60 CELLS | ANTIRETROVIRAL NUCLEOSIDE | ALZHEIMERS-DISEASE | LENGTH | MICROBIOLOGY | IMMUNOLOGY | CANCER | CD8(+) T-CELLS | IN-VITRO | THERAPY | INFECTION | UP-REGULATION | Humans | Middle Aged | Aging - drug effects | Antiretroviral Therapy, Highly Active - adverse effects | Male | Telomere - drug effects | Case-Control Studies | Lamivudine - adverse effects | Reverse Transcriptase Inhibitors - adverse effects | Tenofovir | Young Adult | Telomere Shortening | Adenine - adverse effects | HIV Infections - pathology | Time Factors | Polymerase Chain Reaction | Adult | Deoxycytidine - adverse effects | Female | Telomerase - metabolism | Dideoxynucleosides - adverse effects | Emtricitabine | Adenine - analogs & derivatives | Leukocytes, Mononuclear - drug effects | Zidovudine - adverse effects | Anti-HIV Agents - adverse effects | HIV Infections - virology | Risk Factors | Cells, Cultured | Organophosphonates - adverse effects | HIV - pathogenicity | Enzyme Activation - drug effects | Regression Analysis | Telomere - enzymology | HIV Infections - drug therapy | Leukocytes, Mononuclear - enzymology | Telomerase - antagonists & inhibitors | Deoxycytidine - analogs & derivatives | Complications and side effects | Demographic aspects | Physiological aspects | Aging | Research | Telomerase
Journal Article
The Journal of Infectious Diseases, ISSN 0022-1899, 10/2008, Volume 198, Issue 8, pp. 1113 - 1122
Background. Vicriviroc (VCV) is a CCR5 antagonist with nanomolar activity against human immunodeficiency virus (HIV) replication in vitro and in vivo. We... 
HIV/AIDS | Tropisms | RNA | HIV | Placebos | Viruses | AIDS | Infections | Dosage | HIV 1 | Virology | INFECTIOUS DISEASES | MYOCARDIAL-INFARCTION | MICROBIOLOGY | IMMUNOLOGY | HUMAN-IMMUNODEFICIENCY-VIRUS | PROGNOSTIC VALUE | CCR5 ANTAGONIST | INDIVIDUALS | ANTIRETROVIRAL-DRUG-RESISTANCE | SYNCYTIUM-INDUCING PHENOTYPE | EPIDEMIOLOGY | DISEASE PROGRESSION | Piperazines - administration & dosage | Lamivudine - administration & dosage | Humans | Male | RNA, Viral - blood | Reverse Transcriptase Inhibitors - administration & dosage | Viral Load | Zidovudine - administration & dosage | Anti-HIV Agents - administration & dosage | Lamivudine - adverse effects | Reverse Transcriptase Inhibitors - adverse effects | HIV-1 - physiology | Lamivudine - therapeutic use | Adult | Anti-HIV Agents - therapeutic use | Female | Reverse Transcriptase Inhibitors - therapeutic use | Drug Therapy, Combination | CCR5 Receptor Antagonists | Benzoxazines - administration & dosage | Double-Blind Method | Zidovudine - adverse effects | HIV-1 - drug effects | Pyrimidines - administration & dosage | Anti-HIV Agents - adverse effects | HIV Infections - virology | Benzoxazines - adverse effects | Treatment Outcome | CD4 Lymphocyte Count | Piperazines - therapeutic use | Piperazines - adverse effects | Benzoxazines - therapeutic use | Pyrimidines - therapeutic use | Pyrimidines - adverse effects | HIV Infections - drug therapy | Zidovudine - therapeutic use | Lamivudine | Dosage and administration | HIV (Viruses) | Drug therapy | Zidovudine | Index Medicus | Abridged Index Medicus
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 06/2012, Volume 366, Issue 25, pp. 2380 - 2389
Journal Article